Navigation Links
Novel Alternative Approach to Inhibiting Insulin Growth Factor (IGF) May Provide New Treatment for Breast Cancer and Other Cancers
Date:10/24/2007

Potential to halt cancer cell growth without interfering with insulin may

address limitations of current IGF inhibitors

SAN FRANCISCO, Oct. 25 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) (Nasdaq and MTAX: CTIC) and Systems Medicine, LLC (SM), a wholly-owned subsidiary of CTI, announced that preclinical data presented at the 19th annual AACR-NCI-EORTC Symposium show an antibody to IGF-II may solve the problems of low blood sugar associated with drug candidates working through insulin receptor-linked pathways. The data presented is part of CTI's ongoing Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) to develop products targeting the IGF pathway.

"While insulin-related growth factors play an important role in normal glucose metabolism and cell growth, the IGF pathway is increasingly being recognized as a critical contributor to growth of certain types of cancers," said Jack W. Singer, M.D., Chief Medical Officer of CTI. "Many of the current approaches target blocking the IGF receptor or inhibition of post receptor kinases in an attempt to slow or kill tumor cell growth and are often associated with inhibition of insulin's important metabolic functions including maintaining normal blood glucose levels. By developing an antibody that binds to and neutralizes a specific form of insulin growth factor (IGF- II) the anti-tumor benefit may be retained without blocking the insulin receptor or associated post receptor signaling pathways, potentially allowing normal blood glucose and metabolic control."

Depleting soluble ligand (IGF-II) in solid tumor (human breast cancer xenograft) by ligand-specific human monoclonal antibody (Abstract #A59)

Dimiter S. Dimitrov, Ph.D., Head of the Protein Interaction Group of the CCR Nanobiology Program at the NCI's Center for Cancer Research and principal investigator for the NCI on the CRADA, presented data that may provide the first pro
'/>"/>

SOURCE Cell Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase
2. High-Fidelity PCR with a Novel Polymerase Mixture
3. Challenge the Performance of Your Hot-Start PCRs with FastStart Taq DNA Polymerase and the Novel FastStart High Fidelity PCR System
4. Combine High Yield, Great Accuracy and the Prevention of Carry-over Contamination by Using the Novel Expand High FidelityPLUS PCR System
5. Novel MicroRNA Array Technology for Sensitive miRNA Profiling
6. A Novel Process for Gene Expression Profiling of Rat and Mouse Tissues from Formalin-Fixed Paraffin-Embedded Sections Using Microarrays
7. Use of Novel FlashPlate Technology to Measure cAMP Accumulation in Chinese Hamster Ovary Cells Expressing Human -2 Adrenoreceptors
8. ESR1 Gene Expression in Oncology and Metabolic Diseases Using the ASCENTATM System Target Validation and Identification of Novel Disease Indications
9. Novel Bonding Chemistry Imparts Enhanced Polar Selectivity to TSK-GEL ODS-100V Reversed Phase Columns
10. Unique Surface Treatment of Novel TSK-GEL ODS Columns Provide Separation of Aqueous and Fat Soluble Vitamins
11. Life-sciences conference to feature novel research with clinical potential
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014 ... to announce the appointment of John P. Donoghue ... Biotech   in  Geneva . The ... Campus Biotech in Geneva , has ... recognised neuroscientists. John P. Donoghue , founder of ...
(Date:7/11/2014)... -- Researchers have pioneered a revolutionary new way to ... Virtual Finger, allows scientists to move through digital ... using the flat surface of their computer screens. ... orders of magnitude more efficient, saving time, money ... areas of experimental biology. The software and its ...
(Date:7/10/2014)... 10, 2014 Women in the ... to an additional family planning option. Sayana® Press ... at all levels of the health system and ... a widely used contraceptive—Pfizer’s Depo-Provera® (depot medroxyprogesterone acetate)—with ... is the first of four African countries expected ...
(Date:7/10/2014)... 2014 Deep Knowledge Ventures last ... on ‘Commercialising Longevity Research’ and welcomed a host ... London Bioscience Innovation Center for the event, organised ... Analytics Ltd. The meeting highlighted the need for ... for age-related disease, as well as the crucial ...
Breaking Biology Technology:John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 2John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 3Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 2Virtual Finger Enables Scientists To Navigate And Analyze 3D Images Of Complex Biological Structures 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 2DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 3DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 4DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 5DKV Sponsors Forum on Commercialising Longevity Research; Brings Together Scientists, Investors, Entrepreneurs and Celebrities 6
... March 10 Cepheid (Nasdaq:,CPHD) will present at ... 18 at 10:15 a.m. ET at The Boston ... Executive Officer, will provide a corporate overview., ... be,accessed on Cepheid,s Web site at http://www.cepheid.com ...
... (Amex: ANX ) announced today that complete ... ANX-530 (vinorelbine,emulsion) will be published in the 2008 ... in connection with ASCO,s 2008 Annual Meeting,which takes ... Chicago, IL. The abstract,entitled "Tolerability and incidence of ...
... Cell Therapeutics, Inc.,(CTI) (Nasdaq: CTIC ; MTAX) ... Conference on Tuesday, March 18th at 9:00 AM in ... The presentation will also be webcast live with slides, ... be accessed at, http://www.cticseattle.com ., WBBA Invest ...
Cached Biology Technology:Cepheid to Present at Cowen and Company's 28th Annual Healthcare Conference 2Complete ANX-530 Safety Data to be Published in the 2008 Proceedings of the American Society of Clinical Oncology 2Complete ANX-530 Safety Data to be Published in the 2008 Proceedings of the American Society of Clinical Oncology 3
(Date:7/10/2014)... Fe, Albuquerque, and other major cities in New Mexico, ... treated municipal wastewater rather than precious potable water supplies. ... 40% of all golf courses receive treated effluent. Reusing ... , Additionally, golf courses and homeowners alike fertilize their ... fertilizer is nitrate. A New Mexico State University turfgrass ...
(Date:7/10/2014)... 2014  Pomerantz LLP has filed a class ... the "Company")(NYSE-MKT: PVCT) and certain of its officers.  ... Court, Middle District of Tennessee ... class consisting of all persons or entities who ... 17, 2013 and May 22, 2014, both dates ...
(Date:7/10/2014)... , July 1, 2014 Smart ... way for convenience and improved security: NXT-ID, Inc. (OTCBB: NXTD), ... GOOG ), Apple Inc. (NASDAQ: AAPL ... Corporation (NYSE: MA) NXT-ID, Inc., (OTCQB: NXTD) a biometric ... to announce that the second series of 30 second spots ...
Breaking Biology News(10 mins):'Tailored' water -- the latest in lawn care 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 2Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 3Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 4Advantages for Digital Wallets Eliminate Need to Carry Credit Cards - Large Scale CNBC Ad Campaign for Latest Smart Wallet to Commence July 7th 5
... Twenty-five new articles have been posted online ahead of print ... covers a gamut of topics, from microbial mats to super-eruptions; ... articles go through a rigorous peer-review process prior to print. ... for the seventh year in a row, according to a ...
... in the journal Science , Professor Frank Caruso ... The University of Melbourne and his team have developed ... a new-generation particle system with engineered properties. ... of therapeutics in the areas of cancer, vaccines, cardiovascular ...
... 11, 2013 /PRNewswire-iReach/ -- Ida Tin , CEO and ... that, while fertility is a constant theme for forty years ... effective high–tech tools to help women really understand their fertility ... http://photos.prnewswire.com/prnh/20130711/CG45268 ) Available today in the ...
Cached Biology News:Geology tracks eruptions, earthquakes, erosion, extinctions & more 2Geology tracks eruptions, earthquakes, erosion, extinctions & more 3Geology tracks eruptions, earthquakes, erosion, extinctions & more 4Geology tracks eruptions, earthquakes, erosion, extinctions & more 5Geology tracks eruptions, earthquakes, erosion, extinctions & more 6Geology tracks eruptions, earthquakes, erosion, extinctions & more 7Geology tracks eruptions, earthquakes, erosion, extinctions & more 8Geology tracks eruptions, earthquakes, erosion, extinctions & more 9Geology tracks eruptions, earthquakes, erosion, extinctions & more 10Geology tracks eruptions, earthquakes, erosion, extinctions & more 11Geology tracks eruptions, earthquakes, erosion, extinctions & more 12Geology tracks eruptions, earthquakes, erosion, extinctions & more 13Geology tracks eruptions, earthquakes, erosion, extinctions & more 14Geology tracks eruptions, earthquakes, erosion, extinctions & more 15Geology tracks eruptions, earthquakes, erosion, extinctions & more 16Geology tracks eruptions, earthquakes, erosion, extinctions & more 17Geology tracks eruptions, earthquakes, erosion, extinctions & more 18Geology tracks eruptions, earthquakes, erosion, extinctions & more 19Geology tracks eruptions, earthquakes, erosion, extinctions & more 20Geology tracks eruptions, earthquakes, erosion, extinctions & more 21Clue, a Berlin Startup Founded By a Woman, Launches An Intelligent Tracking App That Decodes a Woman's Fertility Cycle 2Clue, a Berlin Startup Founded By a Woman, Launches An Intelligent Tracking App That Decodes a Woman's Fertility Cycle 3
HLA II DG+DR+DP Monoclonal Antibody, Purified, Unconjugated, Clone: IQU9 This antibody is specific for the monomorphic determinant of the HLA Class II beta chains of the human MHC (28 kDa)....
Anti-gp120/160(SIV/mac239) Immunogen: gp120(SIV/mac239) protein (Genebank accession #M33262)...
Phospho-MEF2A(Thr312)...
Tube-O-DIALYZER Floats, small....
Biology Products: